AI assistant
Sending…
IMMUNIC, INC. — Director's Dealing 2017
Jun 15, 2017
10196_dirs_2017-06-15_f33e38c1-5ea5-450b-b409-2c7c2d4cddf4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2017-06-14
Reporting Person: DUNN JOHN MICHAEL (General Counsel and Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-14 | Common Stock | P | 100 | $3.075 | Acquired | 9485 | Direct |
| 2017-06-14 | Common Stock | P | 2400 | $3.0904 | Acquired | 11885 | Direct |
More from IMMUNIC, INC.
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 27
Board/Management Information
2026
May 19
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Regulatory Filings
2026
Apr 30
Board/Management Information
2026
Apr 28
Board/Management Information
2026
Apr 28
Share Issue/Capital Change
2026
Apr 23